A carregar...
Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia
BACKGROUND: Aripiprazole lauroxil (AL), a long-acting injectable antipsychotic for the treatment of schizophrenia, requires 21 days of oral aripiprazole supplementation upon initiation. We report findings from a phase 1 study investigating a nanocrystalline milled dispersion of AL (AL(NCD)) as a pot...
Na minha lista:
| Publicado no: | J Clin Psychopharmacol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6133194/ https://ncbi.nlm.nih.gov/pubmed/30015676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000921 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|